erythromycin &#160; Turanci (Q213511)

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione ^Turanci

17 Nuwamba 2015

DrugBank ID ^Turanci

00199

tsarin sinadaran

Erythromycin A skeletal.svg
765 × 780; 39 KB

criterion used ^Turanci

structure representation with unlabelled terminal carbon atoms ^Turanci

0 references

Erythromycin A.svg
624 × 484; 75 KB

criterion used ^Turanci

structure representation with labelled terminal carbon atoms ^Turanci

0 references

Taro

733.461 dalton

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

stereoisomer of ^Turanci

1 reference

based on heuristic ^Turanci

inferred from InChI ^Turanci

sinadaran dabara

C₃₇H₆₇NO₁₃

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

canonical SMILES ^Turanci

CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

isomeric SMILES ^Turanci

CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

active ingredient in ^Turanci

Erythrocin Stearate ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

750836

retrieved ^Turanci

14 Faburairu 2018

Erythrocin ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

645943

retrieved ^Turanci

14 Faburairu 2018

Ery-Tab ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

202609

retrieved ^Turanci

14 Faburairu 2018

Erygel ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

202614

retrieved ^Turanci

14 Faburairu 2018

EryPed ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

203253

retrieved ^Turanci

14 Faburairu 2018

PCE ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

848114

retrieved ^Turanci

14 Faburairu 2018

Ery ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

798130

retrieved ^Turanci

14 Faburairu 2018

Emcin Clear ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

605264

retrieved ^Turanci

14 Faburairu 2018

Emgel ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

216888

retrieved ^Turanci

14 Faburairu 2018

E.E.S. ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

863600

retrieved ^Turanci

14 Faburairu 2018

World Health Organisation international non-proprietary name ^Turanci

erythromycin (Turanci)

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

erythromycin A (Turanci)

retrieved ^Turanci

19 Oktoba 2016

found in taxon ^Turanci

Aeromicrobium erythreum ^Turanci

1 reference

stated in ^Turanci

The erythromycin biosynthetic gene cluster of Aeromicrobium erythreum ^Turanci

Streptomyces hygroscopicus ^Turanci

1 reference

stated in ^Turanci

Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain ^Turanci

Streptomyces lydicus ^Turanci

3 references

stated in ^Turanci

The Electrospray Ionization - Mass Spectra of Erythromycin A Obtained from a Marine Streptomyces sp. Mutant. ^Turanci

stated in ^Turanci

Complete genome sequencing and antibiotics biosynthesis pathways analysis of Streptomyces lydicus 103. ^Turanci

stated in ^Turanci

Genetic control of polyketide biosynthesis in the genus Streptomyces ^Turanci

Saccharopolyspora erythraea ^Turanci

5 references

stated in ^Turanci

New antibiotics from genetically engineered actinomycetes. I. 2-Norerythromycins, isolation and structural determinations ^Turanci

stated in ^Turanci

Isolation of erythromycin A N-oxide and pseudoerythromycin A hemiketal from fermentation broth of Saccharopolyspora erythraea by thin-layer and high-performance liquid chromatography ^Turanci

stated in ^Turanci

Biosynthesis of erythromycin: origin of the methyl protons ^Turanci

stated in ^Turanci

Macrolide biosynthesis. 6 Mechanism of polyketide chain elongation ^Turanci

stated in ^Turanci

Metabolic Engineering Strategies Based on Secondary Messengers (p)ppGpp and C-di-GMP To Increase Erythromycin Yield in Saccharopolyspora erythraea ^Turanci

Streptomyces albidoflavus ^Turanci

1 reference

stated in ^Turanci

Erythromycin Biosynthesis: Kinetic Studies on a Fully Active Modular Polyketide Synthase Using Natural and Unnatural Substrates ^Turanci

Streptomyces coelicolor ^Turanci

1 reference

stated in ^Turanci

Erythromycin Biosynthesis: Kinetic Studies on a Fully Active Modular Polyketide Synthase Using Natural and Unnatural Substrates ^Turanci

Bacillus subtilis ^Turanci

1 reference

stated in ^Turanci

Characterization of a Cryptic NRPS Gene Cluster in Bacillus velezensis FZB42 Reveals a Discrete Oxidase Involved in Multithiazole Biosynthesis ^Turanci

Pseudoalteromonas ^Turanci

1 reference

stated in ^Turanci

Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp. ^Turanci

medical condition treated ^Turanci

legionnaires' disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

chlamydia infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

chancroid ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

erythrasma ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

urethritis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Ciwon sanyi

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Gastroenteritis

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

acne ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

campylobacteriosis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Tarin jaki

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

staphylococcal infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

anthrax ^Turanci

1 reference

stated in ^Turanci

WikiSkripta ^Turanci

significant drug interaction ^Turanci

amiodarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

anagrelide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

arsenic trioxide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

astemizole ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

azithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

bepridil ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chloroquine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chlorpromazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cisapride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-citalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

clarithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cocaine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

disopyramide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dofetilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

domperidone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dronedarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

droperidol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

escitalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

flecainide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

halofantrine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

haloperidol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

ibutilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

mesoridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-methadone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

moxifloxacin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

ondansetron ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pentamidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pimozide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

probucol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

procainamide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

quinidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sevoflurane ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sotalol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sparfloxacin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-sulpiride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

terfenadine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

thioridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

amiodarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ondansetron ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sunitinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lapatinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

anagrelide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

moxifloxacin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

saquinavir ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

panobinostat ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

zuclopenthixol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pasireotide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bedaquiline ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dasatinib monohydrate ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pazopanib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-hydroxyzine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vandetanib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vardenafil ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nilotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sorafenib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

quinine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

domperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Sildenafil

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ranolazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bosutinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ceritinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tolterodine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aminophylline ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

theophylline monohydrate ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

methylprednisolone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

budesonide ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ergotamine ^Turanci

ergotism ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

lopinavir ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

quetiapine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

simvastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

simvastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vandetanib ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rac-warfarin ^Turanci

Retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alfentanil ^Turanci

central respiratory depression ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

cardiotoxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cyclosporine ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cyclosporine ^Turanci

cholestasis ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cyclosporine ^Turanci

paresthesia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

digoxin ^Turanci

heart arrhythmia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

digoxin ^Turanci

nausea ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

digoxin ^Turanci

amai

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

leukopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

Rashin jini

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

thrombocytopenia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sirolimus ^Turanci

gudawa

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

felodipine ^Turanci

Tachycardia

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

felodipine ^Turanci

flushing ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

felodipine ^Turanci

water retention ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sorafenib ^Turanci

ventricular dysrhythmia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atorvastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

atorvastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pravastatin ^Turanci

rhabdomyolysis ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pravastatin ^Turanci

muscular disease ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sufentanil ^Turanci

central respiratory depression ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eliglustat ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alprazolam

depressed level of consciousness ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alprazolam

ataxia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alprazolam

lethargy ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tacrolimus ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

Motilin receptor ^Turanci

subject has role ^Turanci

agonist ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

1456

https://www.ncbi.nlm.nih.gov/books/n/livertox/Erythromycin

retrieved ^Turanci

17 Agusta 2016

taste receptor type 2 ^Turanci

subject has role ^Turanci

agonist ^Turanci

1 reference

stated in ^Turanci

The Molecular Receptive Ranges of Human TAS2R Bitter Taste Receptors ^Turanci

route of administration ^Turanci

oral administration ^Turanci

0 references

intravenous infusion and defusion ^Turanci

0 references

topical medication ^Turanci

0 references

pregnancy category ^Turanci

Australian pregnancy category A ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category B ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category A ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

adireshin manazarta

last update ^Turanci

10 Agusta 2017

brand ^Turanci

Erythrocin ^Turanci

0 references

has characteristic ^Turanci

bitterness ^Turanci

1 reference

stated in ^Turanci

BitterDB ^Turanci

subject has role ^Turanci

protein synthesis inhibitor ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

antibiotic ^Turanci

4 references

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

Effects of low concentrations of erythromycin, penicillin, and virginiamycin on bacterial resistance development in vitro ^Turanci

retrieved ^Turanci

15 Maris 2018

stated in ^Turanci

Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) ^Turanci

stated in ^Turanci

stated in ^Turanci

Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China ^Turanci

gastrointestinal agent ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1

retrieved ^Turanci

15 Maris 2018

essential medicine ^Turanci

0 references

‎WHO Aware Classification ^Turanci

watch ^Turanci

1 reference

stated in ^Turanci

2023 ‎AWaRe classification‎ ^Turanci

Commons category ^Turanci

Erythromycin

0 references

Identifiers

InChI ^Turanci

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

ULGZDMOVFRHVEP-RWJQBGPGSA-N

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

114-07-8

2 references

stated in ^Turanci

ULGZDMOVFRHVEP-RWJQBGPGSA-N

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

InChIKey ^Turanci

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

8 Afirilu 2021

adireshin manazarta

https://commonchemistry.cas.org/detail?cas_rn=114-07-8

ChemSpider ID ^Turanci

12041

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

(-)-Erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

PubChem CID ^Turanci

12560

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

Reaxys registry number ^Turanci

75000

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

erythromycin A (Turanci)

retrieved ^Turanci

19 Oktoba 2016

75279

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

erythromycin A (Turanci)

retrieved ^Turanci

19 Oktoba 2016

ChEBI ID ^Turanci

42355

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

ERYTHROMYCIN (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

stated in ^Turanci

ChEBI release 2019-10-02 ^Turanci

ChEMBL ID ^Turanci

CHEMBL532

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

ERYTHROMYCIN (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

UniChem compound ID ^Turanci

514117

1 reference

stated in ^Turanci

UniChem ^Turanci

CCDC Number ^Turanci

944506

1 reference

stated in ^Turanci

Cambridge Structural Database ^Turanci

retrieved ^Turanci

10 Janairu 2023

based on heuristic ^Turanci

InChIKey match ^Turanci

CSD Refcode ^Turanci

QIFKEX

1 reference

stated in ^Turanci

Cambridge Structural Database ^Turanci

retrieved ^Turanci

10 Janairu 2023

based on heuristic ^Turanci

InChIKey match ^Turanci

MassBank accession ID ^Turanci

MSBNK-Athens_Univ-AU105402

0 references

MSBNK-Athens_Univ-AU105403

0 references

MSBNK-Athens_Univ-AU105404

0 references

MSBNK-Athens_Univ-AU105405

0 references

MSBNK-Athens_Univ-AU105407

0 references

MSBNK-Athens_Univ-AU105408

0 references

MSBNK-Athens_Univ-AU105409

0 references

MSBNK-Athens_Univ-AU105410

0 references

MSBNK-Athens_Univ-AU105411

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-MPI_for_Chemical_Ecology-CE000001

0 references

MSBNK-MPI_for_Chemical_Ecology-CE000002

0 references

MSBNK-MPI_for_Chemical_Ecology-CE000003

0 references

MSBNK-MPI_for_Chemical_Ecology-CE000004

0 references

MSBNK-MPI_for_Chemical_Ecology-CE000005

0 references

MSBNK-IPB_Halle-PB005801

0 references

MSBNK-IPB_Halle-PB005802

0 references

MSBNK-IPB_Halle-PB005803

0 references

MSBNK-IPB_Halle-PB005804

0 references

MSBNK-Waters-WA002281

0 references

MSBNK-Waters-WA002282

0 references

MSBNK-Waters-WA002283

0 references

MSBNK-Waters-WA002284

0 references

MSBNK-Waters-WA002285

0 references

MSBNK-Waters-WA002286

0 references

MSBNK-Waters-WA002287

0 references

SPLASH ^Turanci

splash10-0a4i-0900020000-c282d6a703a3a812c91a

0 references

splash10-0a4i-0900000000-b11e26802dca28ea88f0

0 references

splash10-0a4i-0900000000-5ea1e94063a49c0d6ddb

0 references

splash10-004i-0000090000-f0fcdc5ed4d00170f2a3

0 references

splash10-001i-0200000900-439b7d31b57ea93dff40

0 references

splash10-0a59-4900000000-1cb488a53f50cba638cf

0 references

splash10-001i-9700000000-239fd7095409362c75bc

0 references

splash10-001i-9000000000-37757a9a6c61ec2bac1b

0 references

splash10-001i-9000000000-2d04ae69b21d82ee0763

0 references

splash10-053r-0500000900-20a1c46dfdef404c9d3e

0 references

splash10-0a59-5900000000-c7e9166d7e79e23023a5

0 references

splash10-053r-9800000000-07e4c66bcd0be93f7c09

0 references

splash10-001i-9200000000-553fb27002eceacb9270

0 references

splash10-001i-9000000000-9725c29b26f7cbbef576

0 references

splash10-004i-0000090100-c815622b0bac716ba224

0 references

splash10-001i-0000020900-78ac24c4a3447cf2cb78

0 references

splash10-004i-0000090400-0c8362975e5b8d5441bb

0 references

splash10-004i-0200090000-b4daabb8616be713f34c

0 references

splash10-0a4i-0900020000-595b522fe60bb668626a

0 references

splash10-004i-0041090000-e9aadb2dff7c545dfce4

0 references

splash10-004i-0020092000-6a2a3f6a74deed47dd72

0 references

splash10-056r-0070390000-4f9cd4f2a3b1e945ccfa

0 references

splash10-0fw9-0004960000-669f9bf82a144b4b5cdb

0 references

splash10-001r-0000000900-f7ae9c17268cd9b4d606

0 references

splash10-004i-0000090000-44a960c1f6e01d89c752

0 references

splash10-004i-0000090100-d758ebaa209147489967

0 references

splash10-056r-1195478423-a6488f4142a514bb6e82

0 references

splash10-0a4i-1900040000-dcc0d5eb92e2043424ea

0 references

splash10-006t-2592200000-95c1ae1f3e60aaf02e45

0 references

splash10-057i-0200091800-758c187d495c0dc9e596

0 references

HSDB ID ^Turanci

3074

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

3074

28 Oktoba 2019

laƙabi

Erythromycin (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID4022991

1 reference

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID102991

0 references

LiverTox ID ^Turanci

0 references

NSC number ^Turanci

55929

0 references

756759

0 references

EC number ^Turanci

204-040-1

1 reference

stated in ^Turanci

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

ECHA Substance Infocard ID ^Turanci

100.003.673

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.003.673

retrieved ^Turanci

27 Disamba 2018

laƙabi

Erythromycin (Turanci)

quotation ^Turanci

CAS no.: 114-07-8 (Turanci)

AGROVOC ID ^Turanci

c_10665

0 references

AICS Chemical ID (BEING DELETED) ^Turanci

1352

0 references

Lambar ATC

D10AF02

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Erythromycin (Turanci)

17 Nuwamba 2015

J01FA01

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Erythromycin (Turanci)

17 Nuwamba 2015

S01AA17

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Erythromycin (Turanci)

17 Nuwamba 2015

ATCvet ^Turanci

QJ51FA01

0 references

Guide to Pharmacology Ligand ID ^Turanci

1456

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

erythromycin-A (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

MeSH descriptor ID ^Turanci

subject named as ^Turanci

Erythromycin

0 references

Lambar itace MeSH

D02.540.576.500.992

0 references

RxNorm ID ^Turanci

4053

1 reference

stated in ^Turanci

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

DrugBank ID ^Turanci

00199

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

Human Metabolome Database ID ^Turanci

HMDB0014344

1 reference

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

UNII ^Turanci

63937KV33D

1 reference

stated in ^Turanci

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

MedlinePlus drug identifier ^Turanci

a682381

route of administration ^Turanci

oral administration ^Turanci

0 references

a613018

route of administration ^Turanci

eye contact ^Turanci

0 references

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD002345

0 references

DrugCentral ID ^Turanci

1048

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

D00140

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

erythromycin A (Turanci)

retrieved ^Turanci

19 Oktoba 2016

LIPID MAPS ID ^Turanci

LMPK04000006

0 references

PDB ligand ID ^Turanci

ERY

0 references

CAB ID ^Turanci

150783

1 reference

stated in ^Turanci

CAB Thesaurus ^Turanci

retrieved ^Turanci

6 Afirilu 2020

DeCS ID ^Turanci

28027

0 references

electronic Essential Medicines List medicine ID ^Turanci

228

0 references

Encyclopædia Britannica Online ID ^Turanci

science/erythromycin

subject named as ^Turanci

erythromycin

0 references

Encyclopedia of China (Third Edition) ID ^Turanci

494838

0 references

Freebase ID ^Turanci

/m/02r51

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

28 Oktoba 2013

Gran Enciclopèdia Catalana ID ^Turanci

eritromicina

0 references

Gran Enciclopèdia Catalana ID (former scheme) ^Turanci

0103930

0 references

KBpedia ID ^Turanci

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

stated in ^Turanci

KBpedia ^Turanci

retrieved ^Turanci

9 Yuli 2020

Microsoft Academic ID ^Turanci

2780206985

0 references

OpenAlex ID ^Turanci

C2780206985

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

adireshin manazarta

PDB structure ID ^Turanci

4ZJQ

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4ZJQ (Turanci)

retrieved ^Turanci

19 Oktoba 2016

1YI2

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

1YI2 (Turanci)

retrieved ^Turanci

19 Oktoba 2016

3AOC

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

3AOC (Turanci)

retrieved ^Turanci

19 Oktoba 2016

3J7Z

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

3J7Z (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4M83

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4M83 (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4V7X

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4V7X (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4V7U

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4V7U (Turanci)

retrieved ^Turanci

19 Oktoba 2016

3J5L

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

3J5L (Turanci)

retrieved ^Turanci

19 Oktoba 2016

5JTE

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

5JTE (Turanci)

retrieved ^Turanci

19 Oktoba 2016

2J0D

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

2J0D (Turanci)

retrieved ^Turanci

19 Oktoba 2016

3FRQ

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

3FRQ (Turanci)

retrieved ^Turanci

19 Oktoba 2016

5JU8

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

5JU8 (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4ZJL

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4ZJL (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4ZJO

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4ZJO (Turanci)

retrieved ^Turanci

19 Oktoba 2016

2IYF

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

2IYF (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4WFN

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4WFN (Turanci)

retrieved ^Turanci

19 Oktoba 2016

1JZY

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

1JZY (Turanci)

retrieved ^Turanci

19 Oktoba 2016

Quora topic ID ^Turanci

1 reference

stated in ^Turanci

Quora ^Turanci

Store medisinske leksikon ID ^Turanci

erytromycin

mapping relation type ^Turanci

exact match ^Turanci

subject named as ^Turanci

erytromycin

1 reference

stated in ^Turanci

Store norske leksikon ^Turanci

retrieved ^Turanci

29 Mayu 2020

UK Parliament thesaurus ID ^Turanci

420911

subject named as ^Turanci

Erythromycin

0 references

UMLS CUI ^Turanci

C0014806

1 reference

stated in ^Turanci

mzspec:GNPS:GNPS-LIBRARY:accession:CCMSLIB00006685311

UNII ^Turanci

erythromycin (Turanci)

retrieved ^Turanci

17 Nuwamba 2016

Universal Spectrum Identifier ^Turanci

0 references

UNSPSC Code ^Turanci

51101570

0 references

WikiProjectMed ID ^Turanci